Piper Sandler Sees 13% Downside in Rocket Lab Even After a Record Quarter

Piper Sandler maintained a Neutral rating on Rocket Lab (RKLB) but cut its price target to $58 from $83, citing uncertainty around Neutron rocket's launch date. Despite record revenue and backlog, earnings expectations for 2027 were reduced to 3 cents per share. The stock is down 56% from its May high.

Original reporting
Published Nov 11, 2026, 9:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 11, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Piper Sandler Sees 13% Downside in Rocket Lab Even After a Record Quarter — source image
Decision brief

The 30-second read

$RKLBBearishHigh
01

Why it matters

The downgrade adds downside pressure and may trigger short‑term selling, while the strong backlog offers a longer‑term catalyst if launch timelines improve.

02

Market read

Analyst target cut after earnings creates immediate trading relevance for RKLB.

03

What to watch

Record $3.57 bn backlog and rising launch demand may support longer‑term upside despite short‑term uncertainty.

Relevance 7/10Novelty 7/10Timing: post-market

Background

Rocket Lab reported record revenue and backlog but missed earnings expectations; analyst Piper Sandler lowered its target citing launch‑date risk.

Company-level read

Ticker impact

$RKLBBearishHigh confidence
Context

Piper Sandler cut Rocket Lab's price target to $58, 13% below the current price, after a record‑revenue quarter but a loss and no Neutron launch date.

Expected impact

likely pressure as the market prices in the target cut and launch‑date uncertainty.

Evidence & confidence

The downgrade is a fresh, material change with a specific price target; investors typically react negatively to such guidance.

Market effects

Space launch sector may see broader valuation compression as analysts scrutinize launch schedules.

US small‑cap and growth investors could adjust exposure to Rocket Lab and similar firms.

Limited to investors tracking the commercial space industry.

Counterpoint

If Neutron's launch materializes on schedule, the backlog and revenue growth could drive a rally.

Key entities

  • Rocket Lab

    Space launch provider (ticker RKLB).

  • Piper Sandler

    Equity research firm issuing the downgrade.

Related articles

$RKLBMed

Could Rocket Lab Actually Climb 56%? Or Is Morgan Stanley Totally Wrong?

Morgan Stanley reduced its price target for Rocket Lab to $103, 56% above its Nov. 11 close of $66.15, while maintaining an Overweight rating. The company sold $2.4B in stock Q3 and delayed Neutron's first launch to 2027. Analysts expect 3 cents EPS for 2027, down from 16 cents a year ago. Rocket Lab reported record revenue of $268M, up 73%, but a wider GAAP loss of 12 cents per share.

$RKLBMedAI 8/10

$8 Billion Merger Stuck at FCC: SpaceX Accuses Iridium of Using Spectrum Objections to Block Starlink Ground Stations — BigGo Finance

Rocket Lab's $8B acquisition of Iridium Communications faces FCC review opposition from SpaceX, which claims Iridium's spectrum objections are anticompetitive. The deal, valued at $54 per share, is expected to close in 2027. SpaceX seeks to include Iridium's spectrum behavior in the FCC's public-interest assessment, while Rocket Lab and Iridium argue the merger is pro-competitive. The FCC must decide whether to consider spectrum disputes in merger reviews.

$RKLBHighAI 8/10

Rocket Lab CEO Says It Could Be ‘Extremely Profitable’ Without Neutron — But SpaceX Is Not The Only Reason It’s Building The Rocket

Rocket Lab CEO Peter Beck sees a $1 trillion market in space services, beyond the $10-20 billion launch market. The company's proposed $8 billion acquisition of Iridium Communications (IRDM) is expected to close in mid-2027. Neutron rocket's debut is delayed to 2027, with 16 flights booked, including 8 worth $515 million. RKLB stock is down 5% year-to-date, with mixed retail sentiment.

$RKLBMed

Rocket Lab Lands $150M OSC Loan Pledge for Neutron Rocket

Rocket Lab USA secured a conditional $150M loan from the Department of War's Office of Strategic Capital for its reusable Neutron rocket. Funds will expand production and add recovery vessels. The loan is subject to due diligence and other conditions. Neutron is designed to carry 13,000 kg to low Earth orbit, supporting satellite constellations and national security payloads. This is OSC's third $150M space-sector commitment.

$RKLBHighAI 8/10

Rocket Lab posts $268 million quarter, expects Neutron in 2027

Rocket Lab reported Q3 2026 revenue of $267.8M, up 73% YoY, exceeding forecasts. Net loss widened to $79.7M, with adjusted EBITDA at -$18.0M. Space systems revenue grew 88% to $214.8M. Neutron rocket's launch delayed to 2027 due to manufacturing issues. Backlog reached $3.57B, with $1B in new launch contracts. Iridium acquisition pending regulatory approval, expected to close in 2027.